Cargando…

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019

Detalles Bibliográficos
Autores principales:	Temesgen, Zelalem, Kenderian, Saad S., Badley, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836950/ https://www.ncbi.nlm.nih.gov/pubmed/33673930 http://dx.doi.org/10.1016/j.mayocp.2020.12.029

Ejemplares similares

Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Aroldi, Andrea, et al.
Publicado: (2021)

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
por: Temesgen, Zelalem, et al.
Publicado: (2020)

Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019
por: Melody, Megan, et al.
Publicado: (2020)

C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL
por: TEMESGEN, ZELALEM, et al.
Publicado: (2021)

Reply: Coronavirus disease 2019 vaccines in pregnancy
por: Craig, Amanda M., et al.
Publicado: (2021)

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
por: Temesgen, Zelalem, et al.
Publicado: (2022)

1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation
por: Chappell, Dale, et al.
Publicado: (2022)

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
por: Temesgen, Zelalem, et al.
Publicado: (2021)

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial
por: Temesgen, Zelalem, et al.
Publicado: (2023)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

Reply: Clinical studies on coronavirus disease 2019 (COVID-19) in the WHO registry network
por: Verma, Henu Kumar, et al.
Publicado: (2022)

Reply to ‘Coronavirus disease 2019 prevention, control and modelling metrics’
por: Chatterjee, Kaushik, et al.
Publicado: (2020)

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”
por: Coto‐Hernández, Rubén, et al.
Publicado: (2020)

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

CRISPR Taking the Front Seat in Immunotherapy
por: Kenderian, Saad S., et al.
Publicado: (2020)

Bibliometric analysis reveals the Mediterranean diet can benefit against coronavirus disease 2019
por: Li, Chenqinyao, et al.
Publicado: (2023)

Reply to letter to the editor to “clinical significance of micronutrient supplements in patients with coronavirus disease 2019: A comprehensive systematic review and meta-analysis”
por: Beran, Azizullah, et al.
Publicado: (2023)

Reply to: “Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?””
por: Bril, Fernando, et al.
Publicado: (2021)

40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial
por: Temesgem, Zelalem, et al.
Publicado: (2021)

Reply to “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care”
por: Ather, Amber, et al.
Publicado: (2020)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

In Reply to the Letter to the Editor Regarding “Coronavirus Disease 2019 (COVID-19) and Neurosurgery: Literature and Neurosurgical Societies Recommendations Update”
por: Raffa, Giovanni, et al.
Publicado: (2020)

Reply to the Letter to the Editor: infection control protocol inside computed tomography suites during coronavirus disease 2019 outbreak
por: Yamashiro, Tsuneo, et al.
Publicado: (2020)

Reply to: Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data
por: Craig, Amanda M., et al.
Publicado: (2021)

Reply to cai et al regarding “vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis”
por: Kotlyar, Alexander M., et al.
Publicado: (2022)

Reply to Letter to Editor: Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination – A Case Report and Review of Literature
por: Abrishami, Mojtaba, et al.
Publicado: (2023)

Coronavirus Disease 2019: Implications for Clinical Dental Care
por: Jadhav, Ganesh R., et al.
Publicado: (2020)

Clinical characteristics of hemodialysis patients with coronavirus disease 2019
por: Huang, Shenghua, et al.
Publicado: (2022)

In Reply to the Letter to the Editor Regarding “Coronavirus Neurosurgical/Head and Neck Drape to Prevent Aerosolization of Coronavirus Disease 2019 (COVID-19): The Lenox Hill Hospital/Northwell Health Solution”
por: Pena, Robert C.F., et al.
Publicado: (2020)

A Case of Coronavirus Disease 2019 Treated With Ciclesonide
por: Nakajima, Kento, et al.
Publicado: (2020)

Coronavirus disease 2019 and pregnancy
por: Rasmussen, Sonja A., et al.
Publicado: (2021)

Coronavirus disease 2019 in pregnancy
por: Tang, Mi, et al.
Publicado: (2021)

Reply to letter to the editor: “Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019”
por: Erdoğan, Mehmet, et al.
Publicado: (2022)

Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
por: Ward, S E
Publicado: (2007)

Coronavirus Disease 2019: The Impact of Coronavirus Disease 2019 on the Use of Air Ambulances for International Medical Assistance
por: Duchateau, François-Xavier, et al.
Publicado: (2021)

Increase in humidifier lung cases owing to coronavirus disease 2019
por: Shimoda, Masafumi, et al.
Publicado: (2021)

Clozapine toxicity and coronavirus disease 2019: A case report
por: Sagué-Vilavella, Maria, et al.
Publicado: (2022)

Mechanisms of Stroke in Coronavirus Disease 2019
por: Montalvan, Victor, et al.
Publicado: (2020)

Vertical transmission of coronavirus disease 2019
por: Martinez-Portilla, Raigam Jafet
Publicado: (2021)

Future for coronavirus disease 2019: India
por: Roy, Manas Pratim
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sishir99qq5n0a7cs1tl9ls418